[home]
[thesaurus]
Click Here to return To Results
Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada
Storke 38:1952-1955,1732, Yip,T.R. &Demaerschalk,B.M., 2007
See this aricle in Pubmed
Article Abstract
We estimate that even small increases in the proportion of all Canadian ischemic stroke patients receiving tPA could result in substantial realized savings for Canadas health care system.
Related Tags
(click to filter results - removes previous filter)
cerebrovascular accident,acute management of
cerebrovascular accident,cost of
cerebrovascular accident,thrombolytic agents in treatment
cost
cost effectiveness
fibrinolytic agents
tissue plasminogen activator,intravenous
treatment of neurologic disorder
Click Here to return To Results